A feed premix functional package containing metformin and its preparation method and application
By adding metformin, sodium butyrate, lipoic acid, rumencholine and B vitamins to the feed, the problems of obesity and postpartum nutritional metabolic diseases of cows in the late stage of lactation are solved, and the healthy weight loss and production performance of cows are achieved Improvement extends the healthy lifespan and economic value of cows.
Patent Information
- Application Number
- CN202310552192.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-17
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2043-05-17
AI Technical Summary
The existing technology has not effectively solved the problems of obesity, reduced insulin sensitivity and postpartum nutritional metabolic diseases in cows in the late stage of lactation. Traditional methods such as reducing dietary energy concentration or increasing crude material supply cannot truly lose weight, which will lead to weight gain in cows, affecting Cows are produced in performance and health.
Provide a feed premix functional package containing metformin, sodium butyrate, lipoic acid, rumencholine and B vitamins, made by grinding and mixing, to replace essence, promote energy metabolism and fat oxidation of dairy cows. and antioxidant functions, reduce blood fatty acid content, improve milk fat and protein content, and control liver function and body condition.
Effectively promote the weight loss of cows, improve lactation performance and milk production, reduce the incidence of postpartum diseases, prolong the biological and economic value of cows, improve the economic benefits of farms, and improve the health of cows and liver metabolic functions.
Smart Images

Figure GDA0005044526940000091 
Figure GDA0005044526940000101 
Figure GDA0005044526940000111
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of feed, and in particular to a feed premix functional package containing metformin, a preparation method and an application thereof. Background Art
[0002] Milk plays an important role in the nutritional needs of the people, and the feeding and management of dairy cows plays a decisive role in milk production. The lactation cycle of dairy cows is generally divided into the early stage (parturition to 100 days after parturition), the middle stage (101 days after parturition to 200 days after parturition) and the late stage (201 days after parturition to stop lactation). Many studies and ranchers have focused on the early stage of lactation, because the amount of milk produced by dairy cows accounts for about half of the total output of the entire lactation period. In the late stage of lactation, the amount of milk produced gradually decreases, which has received less attention; more and more studies have shown that the reduction process in the late stage of lactation can be regulated by nutrition to increase the output of the entire lactation period. In addition, due to the approaching dry period, the health of the dairy cow's body at this stage has a huge impact on the transition to the peripartum period and the next lactation cycle, especially in terms of nutritional metabolic diseases. Often accompanied by a decrease in milk production and a decrease in energy output, excessive fat accumulation is likely to occur, leading to obesity in dairy cows. According to a survey, the proportion of obese cows in the late lactation period exceeds 10% of the dairy cow population. Therefore, controlling the late lactation period to prevent dairy cow obesity has important significance and practical economic value. Therefore, it is necessary to develop a functional package or similar products specifically for obese dairy cows in the late lactation period from the perspective of nutritional regulation in feed, so as to promote the energy metabolism and weight loss of dairy cows, reduce the incidence of postpartum dairy cows, and thus enhance the production potential of dairy cows, effectively extend the biological value and economic value of dairy cows, and promote the further development of the dairy farming industry.
[0003] In the late lactation period, dairy cows store too much body fat, which leads to increased inflammation, excessive metabolic burden on the liver, and reduced insulin sensitivity. Metformin, known as the "magic drug" for lowering blood sugar in humans, has been listed as the first choice for the treatment of diabetes by the World Health Organization and drug guidelines in many countries. More than 100 million people around the world take it every day to lower blood sugar and weight. It has the functions of promoting insulin mobilization, regulating liver metabolic stress, promoting glucose and lipid metabolism, promoting weight loss, and reducing inflammatory response. This has been confirmed in many studies on humans and mice, but there is no data showing the application of metformin in the control of body condition and insulin sensitivity of obese dairy cows. Reducing the amount of concentrate in the diet of dairy cows in the late lactation period (correspondingly, increasing roughage) will lead to rumen fermentation in the form of acetic acid, reducing the overall energy supply of dairy cows, and thus reducing milk production. On the other hand, although providing high roughage can reduce the energy concentration of the diet, it cannot really make dairy cows lose weight because of its increased feed intake, but it will make them fatter. Propionic acid is a sugar substrate. Therefore, the regulation of butyric acid, another important and main substrate produced by rumen microbial fermentation, is selective. Studies in broilers, obese mice and obese people have shown that butyrate (sodium) can not only provide energy for organisms, but also regulate energy and material metabolism in the body in the form of signal molecules. The mechanism involved is that sodium butyrate regulates fat metabolism by promoting fat oxidation and decomposition and reducing fat synthesis. However, there has been no report on reducing cattle obesity, promoting lactation performance and reducing postpartum diseases by adding sodium butyrate to dairy cow diets. As a universal antioxidant, lipoic acid has been used in aquaculture and broiler farming. It inhibits oxidation and scavenges free radicals, and improves the body's antioxidant function by increasing the regeneration of other antioxidant substances in the body. It has the ability to improve animal antioxidant capacity and improve fat deposition, thereby improving meat quality and taste; in addition, lipoic acid is a coenzyme in the pyruvate dehydrogenase complex and α-ketoglutarate dehydrogenase complex in the body's tricarboxylic acid cycle. It catalyzes the generation and transfer of acyl groups, promotes lipid metabolism, and improves body fat composition. However, lipoic acid has not yet been used in dairy cow lactation, especially in the late lactation period, to regulate dairy cow fat metabolism. Rumen-bypass choline can promote the liver's ability to transport fat, promote the oxidation of fat outside the liver, and prevent fatty liver. It is a good additive commonly used to protect the liver in peripartum dairy cows. Rumen-bypass vitamin B2 and rumen-bypass vitamin B5 promote the oxidation of carbohydrates, fats, proteins and other substances in the body to provide energy, and promote the body's energy metabolism; vitamin B3 maintains redox reactions and promotes the body's antioxidant capacity; B vitamins are essential for dairy cows. Even though some B vitamins can be synthesized in the rumen of dairy cows, it is obviously insufficient for dairy cows in the late lactation period to meet lactation and fetal development. Therefore, it is necessary to add it to the diet to strengthen its content in order to meet the nutritional metabolic needs of animals and maintain the health of animals.
[0004] So far, there have been no reports on the combined use of metformin, sodium butyrate, lipoic acid, rumen bypass choline and B vitamins (B2, B3 and B5) in reducing weight loss in late lactation dairy cows, improving lactation performance in late lactation and improving peripartum health.
[0005] To this end, the present invention aims to provide a feed premix functional package containing metformin, a preparation method and an application thereof, so as to solve the above-mentioned problems in the prior art. Summary of the invention
[0006] The purpose of the present invention is to solve the above problems and provide a feed premix functional package containing metformin and a preparation method and application thereof.
[0007] In order to achieve the above object, the technical solution of the present invention is as follows:
[0008] The present invention provides a feed premix functional package containing metformin, wherein the functional package is prepared by mixing the following raw materials in parts by weight:
[0009] 1-3 parts of metformin, 8-15 parts of sodium butyrate, 0.8-1.2 parts of lipoic acid, 4-6 parts of rumen bypass choline, 0.03-0.04 parts of rumen bypass vitamin B2, 0.3-0.4 parts of rumen bypass vitamin B3, 0.04-0.06 parts of rumen bypass vitamin B5 and 15-20 parts of mulberry leaf powder as a carrier.
[0010] Optionally, the functional package includes the following raw materials in parts by weight: 1-3 parts of metformin, 8-15 parts of sodium butyrate, 0.8-1.2 parts of lipoic acid, 4-6 parts of rumen bypass choline, 0.03-0.04 parts of rumen bypass vitamin B2, 0.3-0.4 parts of rumen bypass vitamin B3, 0.04-0.06 parts of rumen bypass vitamin B5 and 15-20 parts of mulberry leaf powder as a carrier.
[0011] The present invention also provides a method for preparing the functional package: each component is ground, sieved, and fully stirred and mixed in a mixer to prepare the functional package.
[0012] In a second aspect, the present invention provides the use of the functional package in feeding obese dairy cows in the late lactation period or in preparing feed for obese dairy cows in the late lactation period.
[0013] Furthermore, the application of the above functional package in any of the following also falls within the protection scope of the present invention:
[0014] 1) Application in promoting feed intake and milk production of obese dairy cows in the late lactation period;
[0015] 2) Application in the preparation of feed for promoting feed intake and milk production of obese dairy cows in the late lactation period;
[0016] 3) Application in increasing the milk fat content and milk protein content of obese dairy cows in the late lactation period;
[0017] 4) Application in the preparation of feed for increasing the milk fat content and milk protein content of obese dairy cows in the late lactation period;
[0018] 5) Application in reducing the content of triglycerides and free fatty acids in the blood of obese dairy cows in the late lactation period;
[0019] 6) Application in the preparation of feed for reducing the content of triglycerides and free fatty acids in the blood of obese dairy cows in the late lactation period;
[0020] 7) Application in reducing the content of alanine aminotransferase and aspartate aminotransferase in the blood of obese dairy cows in the late lactation period;
[0021] 8) Application in the preparation of feed for reducing the content of alanine aminotransferase and aspartate aminotransferase in the blood of obese dairy cows in the late lactation period;
[0022] 9) Application in reducing the body condition of obese dairy cows in the late lactation period;
[0023] 10) Application in the preparation of feed for reducing the body condition of obese dairy cows in the late lactation period;
[0024] 11) Application in controlling the body condition of dairy cows entering the peripartum period and reducing the range of body condition changes during the peripartum period;
[0025] 12) Application in the preparation of feed for controlling the body condition of dairy cows entering the peripartum period and reducing the range of body condition changes during the peripartum period;
[0026] 13) Application in reducing the content of triglycerides and free fatty acids in the blood of peripartum obese dairy cows;
[0027] 14) Application in the preparation of feed for reducing the content of triglycerides and free fatty acids in the blood of peripartum obese dairy cows;
[0028] 15) Application in reducing the content of alanine aminotransferase and aspartate aminotransferase in the blood of peripartum obese dairy cows;
[0029] 16) Application in the preparation of feed for reducing the content of alanine aminotransferase and aspartate aminotransferase in the blood of peripartum obese dairy cows;
[0030] 17) Application in increasing feed intake and reducing disease incidence in peripartum dairy cows;
[0031] 18) Application in the preparation of feed for increasing feed intake and reducing disease incidence in periparturient dairy cows.
[0032] Furthermore, in order to better exert the effect of the functional package, the feed prepared by the functional package is freely consumed by each cow every day, and the feeding period is at least more than 1 month.
[0033] Compared with the prior art, this solution has the following beneficial effects:
[0034] 1. In the present invention, metformin has the functions of promoting insulin mobilization, regulating liver metabolic stress, promoting glucose and lipid metabolism and promoting weight loss, and reducing the body's inflammatory response; sodium butyrate regulates lipid metabolism by increasing fat oxidation and decomposition and reducing fat synthesis, improves energy metabolism, and improves the body's antioxidant function by increasing the body's antioxidant enzyme activity, thereby promoting weight loss. Lipoic acid promotes lipid metabolism by catalyzing the production and transfer of acyl groups; it improves the body's antioxidant function by inhibiting oxidation and scavenging free radicals, and by improving the regeneration of other antioxidants in the body; rumen-bypass choline has the ability to promote the liver's fat transport, promote the oxidation of fat outside the liver, and prevent fatty liver; rumen-bypass vitamin B2 and rumen-bypass vitamin B5 promote the oxidation of carbohydrates, fats, proteins and other substances in the body to provide energy, and promote the body's energy metabolism; vitamin B3 maintains redox reactions and promotes the body's antioxidant capacity; mulberry leaf powder is used as a carrier to meet protein requirements when replacing concentrates, and the carrier has a high content of bioactive ingredients (such as flavonoids, steroids and alkaloids, etc.), which have antioxidant, anti-inflammatory, lipid-lowering and blood sugar-lowering effects.
[0035] 2. The functional package of the present invention is easy to prepare, and while increasing the feed intake of dairy cows in the late lactation period, it effectively increases the milk protein and milk fat content, thereby improving economic benefits;
[0036] 3. The functional package of the present invention can effectively reduce the content of triglycerides and free fatty acids in the blood of dairy cows in the late lactation period, effectively promote the metabolism of fat in the liver of dairy cows, and reduce the accumulation of fat in the liver; and can also effectively reduce the activity of liver function-related enzymes (alanine aminotransferase and aspartate aminotransferase content), thereby maintaining liver health and body nutrient metabolism;
[0037] 4. The functional package of the present invention can effectively control the range of changes in the body condition of periparturient dairy cows, reduce the blood lipid metabolism and liver function indicators of periparturient dairy cows, promote the feed intake of periparturient dairy cows, and reduce the incidence of nutritional metabolic diseases in the initial stage of the next lactation period; it is convenient to ensure the healthy transition of periparturient dairy cows and can effectively extend the biological value and economic value of dairy cows. DETAILED DESCRIPTION
[0038] In order to enable those skilled in the art to better understand the solution of the present invention, the technical solution of the present invention will be further described in detail below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in the field without creative work should fall within the scope of protection of the present invention.
[0039] It should be noted that, in the absence of conflict, the embodiments of the present invention and the features in the embodiments may be combined with each other.
[0040] In view of the current situation in my country's dairy farming industry that dairy cows in the late lactation period are too obese, have poor production performance in the late lactation period, have poor liver fat metabolism ability, have a high incidence of postpartum nutritional metabolic diseases, and create low economic value, the present invention provides a functional package for obese dairy cows in the late lactation period, so as to promote the energy metabolism of dairy cows, reduce the incidence of postpartum dairy cows, and thereby improve the health level and lactation performance.
[0041] The invention provides a functional package, which is prepared by mixing the following raw materials in parts by weight: 1-3 parts of metformin, 8-15 parts of sodium butyrate, 0.8-1.2 parts of lipoic acid, 4-6 parts of rumen bypass choline, 0.03-0.04 parts of rumen bypass vitamin B2, 0.3-0.4 parts of rumen bypass vitamin B3, 0.04-0.06 parts of rumen bypass vitamin B5 and 15-20 parts of mulberry leaf powder as a carrier.
[0042] Metformin is used to lower blood sugar and control body weight in humans. It has the function of promoting insulin mobilization, regulating liver metabolic stress, promoting glucose and lipid metabolism to promote weight loss, and has the function of reducing inflammatory response. However, metformin has not yet been applied to the lactation period of dairy cows, especially in the late lactation period of dairy cows to regulate dairy cow glucose and lipid metabolism. Sodium butyrate is mainly used in the broiler industry and the human nutrition and health care industry to regulate energy metabolism (especially the liver), reduce the incidence of diseases (such as inflammatory enteritis), control body condition to reduce obesity, control the fat ratio of broilers, and improve taste and flavor; the dairy cow field is mainly used to enhance the immune function of newborn calves, accelerate rumen development, reduce the incidence of diseases such as diarrhea and weaning stress use; the above-mentioned application of sodium butyrate in the dairy cow field is mainly its role in enhancing immunity and promoting growth and development in young animals, and does not pay attention to its other functions, nor is it used for a long time in the lactation period of dairy cows. After a lot of experimental exploration and research, the inventor of the present invention found that sodium butyrate can control the body condition of dairy cows and reduce obesity like broilers, achieving very good dairy cow production practice results. As a universal antioxidant, lipoic acid has been used in aquaculture and broiler farming. It inhibits oxidation and removes free radicals, and improves the body's antioxidant function by increasing the regeneration of other antioxidant substances in the body. It has the ability to improve animal antioxidant capacity and improve fat deposition, thereby improving meat quality and taste. In addition, lipoic acid is a coenzyme in the pyruvate dehydrogenase complex and α-ketoglutarate dehydrogenase complex in the body's tricarboxylic acid cycle. It promotes lipid metabolism and improves body fat composition by catalyzing the production and transfer of acyl groups. However, lipoic acid has not yet been used in the lactation period of dairy cows, especially in the late lactation period of dairy cows, to regulate dairy cow fat metabolism. Rumen-passing choline has the ability to promote the liver's ability to transport fat, promote the oxidation of fat outside the liver, and prevent fatty liver. It is a commonly used good additive for protecting the liver in periparturient dairy cows. Rumen-passing vitamin B2 and rumen-passing vitamin B5 promote the oxidation of carbohydrates, fats, proteins and other substances in the body to provide energy, and promote the body's energy metabolism; vitamin B3 maintains redox reactions and promotes the body's antioxidant capacity; B vitamins are essential for dairy cows. Even though a portion of B vitamins can be synthesized in the rumen of dairy cows, it is obviously insufficient for dairy cows in the late lactation period to meet the needs of lactation and fetal development, so it is necessary to add it from the diet to strengthen its content in order to meet the nutritional metabolism needs of animals and maintain the health of the animal body. Specifically, metformin can be selected from 1 to 3 parts or any range between these weight parts, and metformin does not need to be protected by coating (released by rumen). Sodium butyrate can be selected from 8 to 15 parts or any range between these weight parts, and sodium butyrate does not need to be protected by coating (released by rumen). Lipoic acid can be selected from 0.8 to 1.2 parts or any range between these weight parts, and does not need to be protected by coating (released by rumen).Lipoic acid can be selected from 0.8 to 1.2 parts or any range between these parts by weight, and it is not necessary to use a protected form such as coating (rumen release). Choline, which needs to be coated to be released through the rumen, can be selected from 4 to 6 parts or any range between these parts by weight. B vitamins all need to use a rumen-passing form, vitamin B2 can be selected from 0.03 to 0.04 parts or any range between these parts by weight; vitamin B3 can be selected from 0.3 to 0.4 parts or any range between these parts by weight; vitamin B5 can be selected from 0.04 to 0.06 parts or any range between these parts by weight. The carrier uses mulberry leaf powder because of its higher protein and bioactive component content, and correspondingly it can be selected from 15 to 20 parts or any range between these parts by weight. The functional package of the present invention has low cost, is easy to obtain, and is particularly suitable for use in large ranches.
[0043] The present invention is further described below by means of specific examples. Unless otherwise specified, the materials in the following examples are all commonly used materials in the art and can be obtained from commercial sources.
[0044] Example 1
[0045] Preparation of the functional package: After grinding each component, sieving, and fully stirring and mixing in a mixer to obtain the functional package.
[0046] Example 2
[0047] The functional package of Example 1 is used to supply obese dairy cows in the late lactation period to improve lactation performance, reduce obesity and postpartum nutritional metabolic diseases.
[0048] 1) Experimental animals and feeding management: 80 obese dairy cows (body condition score> 3.5 points, 5 points system) in the late lactation period (200.5±8.4d; 2.2±0.4 parity) were selected in this experiment and randomly divided into control group, experimental group I, experimental group II and experimental group III, with 20 cows in each group. The experimental treatment lasted for 30 days. During these 30 days, the control group cows were fed the control group diet, the experimental group I cows were supplemented with 100g functional pack to replace 100g concentrate on the basis of feeding the control group diet, the experimental group II cows were supplemented with 300g functional pack to replace 300g concentrate on the basis of feeding the control group diet, and the experimental group III cows were supplemented with 500g functional pack to replace 500g concentrate on the basis of feeding the control group diet. The composition and nutritional level of the pasture total mixed diet are shown in Table 1. The mice were fed at 06:00-09:00 and 16:00-18:00 every day and had free access to drinking water.
[0049] Table 1 Diet composition and nutritional components
[0050]
[0051]
[0052] Note: The ingredients of premixed feed are: vitamins (A2,000,000IU; D3 600,000IU; E 20,000IU) and mineral elements (copper 3,500mg; manganese 5,000mg; zinc 9,800mg; iodine 150mg; selenium 150mg and cobalt 100mg) and 50g each of stone powder and calcium hydrogen phosphate per kg of dry matter.
[0053] 2) Sample collection: The measured data include: dry matter intake, milk production, milk fat rate, milk protein rate, body condition score, serum alanine aminotransferase, serum aspartate aminotransferase, serum free fatty acid content, serum triglyceride content, peripartum body condition score, peripartum feed intake, and postpartum disease incidence. Late lactation data collection method: The body condition of dairy cows on days 1, 10, 20 and 30 was scored (on a 5-point scale, 1 point is very thin and 5 points is very fat) and dry matter intake were measured; milk samples were collected from the morning, noon and evening on days 1, 10, 20 and 30 (mixed in a ratio of 4:3:3 in the morning, noon and evening) to measure milk protein and milk fat rate indicators, and milk production was measured on the same day. Blood indicators, blood was collected from days 1, 10, 20 and 30 to measure the above-mentioned related indicators. Peripartum data collection method: dry matter intake and body condition scores of dairy cows were measured 14 and 7 days before delivery, on the day of delivery, and 7, 14 and 21 days after delivery; blood samples were collected 14 and 7 days before delivery, on the day of delivery, and 7, 14 and 21 days after delivery to measure the above blood indicators; disease incidence 21 days after delivery: the diseases of dairy cows from delivery to 21 days after delivery were recorded, including ketosis, postpartum paralysis, hypocalcemia, retained placenta, metritis, mastitis and displaced abomasum.
[0054] 3) Experimental results: The production performance of dairy cows in the late lactation period, such as dry matter intake, milk production, milk protein rate and milk fat rate, were better than those of the control group, and the experimental group II had the best effect; blood indicators showed that the lipid metabolism (serum free fatty acids and triglyceride content) and liver function (serum alanine aminotransferase and aspartate aminotransferase content) of the experimental group were lower than those of the control group, and the experimental group II had the best effect; and the body condition scores of dairy cows in the experimental group changed significantly, and the experimental group II had the best weight loss effect. After the dairy cows entered the peripartum period (14 days before delivery), the body condition of the experimental group was still lower than that of the control group. The body condition of the experimental group changed less during the entire peripartum period (14 days before delivery to 21 days after delivery), indicating that the proportion of mobilized body fat was lower, which was consistent with the changes in fatty acids and liver function indicators in the blood during the peripartum period, and the experimental group II had the best effect; the dry matter intake during the peripartum period (14 days before delivery to 21 days after delivery) was higher than that of the control group, and the incidence of postpartum diseases was lower than that of the control group, indicating that the overall energy utilization rate of the experimental group of cattle was improved, and the metabolic efficiency of fatty acids was higher, which further improved the health of the cattle body and thus improved the production level. The specific test results are shown in Table 2 below.
[0055] Table 2 Dry matter intake of dairy cows in the late lactation period
[0056]
[0057] Note: Unit: kg / d.
[0058] As shown in Table 2, the dry matter intake of the experimental groups showed a significant trend of increasing with the extension of lactation age, and the effect of Experimental Group II was the best.
[0059] Table 3 Body condition scores of dairy cows in the late lactation period in each group
[0060]
[0061]
[0062] Note: The change range refers to the difference between the body condition scores on day 1 and day 30. The body condition score is based on a 5-point system, with 1 being extremely thin and 5 being extremely fat.
[0063] As shown in Table 3, there was no difference in the initial body condition scores among the groups. The body condition scores of the experimental groups showed a significant trend of decreasing with the extension of lactation age, and the decrease in the experimental group II was the largest, with the best effect.
[0064] Table 4 Lactation performance of dairy cows in the late lactation period of each group
[0065]
[0066] As shown in Table 4, in terms of lactation performance, the experimental groups showed a significant trend of improving milk yield, milk protein rate and milk fat rate as the lactation age increased, and the improvement effect of Experimental Group II was the best.
[0067] Table 5 Liver function and fatty acid metabolism indexes of dairy cows in the late lactation period
[0068]
[0069] As shown in Table 5, the liver function and fatty acid metabolism of the experimental group were significantly lower than those of the control group, and the improvement of the experimental group II was the best, indicating that their lipid metabolism was more efficient and more beneficial to the health of the body.
[0070] Table 6 Dry matter intake of dairy cows in each group during the peripartum period
[0071]
[0072] Note: Unit: kg / d.
[0073] As shown in Table 6, the experimental group had a clear advantage in dry matter intake during the peripartum period (14 days before delivery to 21 days after delivery). The experimental group was higher than the control group at all time points during the entire period, and the improvement effect of Experimental Group II was the best.
[0074] Table 7 Body condition scores of dairy cows in each group during peripartum period
[0075]
[0076] Note: The change range refers to the difference between the body condition score on the 14th day before delivery and the 21st day after delivery. The body condition score is based on a 5-point system, with 1 being extremely thin and 5 being extremely fat.
[0077] As shown in Table 7, the experimental group had a lower body condition score when entering the perinatal period (14 days before delivery), and then as it entered the postpartum stage and needed to mobilize the body's energy reserves, its body condition score changed less, indicating that the proportion of mobilization of the body's energy reserves was low, indicating that the body can make good use of the energy from the diet, which lays an important foundation for the body's health. Throughout the perinatal period, the body's energy reserves in the experimental group II were mobilized the least, the liver burden was smaller, and it was more conducive to the body's health.
[0078] Table 8 Liver function and fatty acid metabolism indexes of dairy cows in the late lactation period
[0079]
[0080] As shown in Table 8, the experimental group had lower fatty acid content and liver enzyme content in the perinatal period (14 days before delivery and 21 days after delivery), indicating that the body metabolizes fatty acids more efficiently and the liver burden is less, and the effect of Experimental Group II is the best.
[0081] Table 9 Nutritional and metabolic diseases of dairy cows in each group within 21 days after delivery
[0082]
[0083] As shown in Table 9, the experimental group had a lower incidence of nutritional metabolic diseases within 21 days after delivery, indicating that after the obese dairy cows in the late lactation period were treated with sodium butyrate to improve the liver fat metabolism level and energy utilization efficiency, it was helpful to reduce the incidence of postpartum diseases in the next litter and improve the long-term health of dairy cows. The addition amount in the experimental group II had the best effect.
[0084] The above specific embodiments are merely explanations of the present invention and are not limitations of the present invention. After reading this specification, those skilled in the art may make modifications to the embodiments without any creative contribution as needed. However, such modifications are protected by the patent law as long as they are within the scope of the claims of the present invention.
Claims
1. A feed premix functional package containing metformin, characterized in that: Made from the following components: Metformin, sodium butyrate, lipoic acid, rumen bypass choline, rumen bypass vitamin B2, rumen bypass vitamin B3, rumen bypass vitamin B5 and mulberry leaf powder.
2. The feed premix functional package containing metformin according to claim 1, characterized in that: It is made from the following raw materials in parts by weight: 1-3 parts of metformin, 8-15 parts of sodium butyrate, 0.8-1.2 parts of lipoic acid, 4-6 parts of rumen bypass choline, 0.03-0.04 parts of rumen bypass vitamin B2, 0.3-0.4 parts of rumen bypass vitamin B3, 0.04-0.06 parts of rumen bypass vitamin B5 and 15-20 parts of mulberry leaf powder as a carrier.
3. The method for preparing the functional package according to any one of claims 1 to 2, characterized in that: The method comprises the following steps: grinding metformin, sodium butyrate, lipoic acid, rumen bypassed choline, rumen bypassed vitamin B2, rumen bypassed vitamin B3, rumen bypassed vitamin B5 and mulberry leaf powder, sieving the mixture, and fully stirring and mixing the mixture in a mixer to obtain the product.
4. Use of the functional package according to claim 1 or 2 in preparing feed for late lactation obese dairy cows, wherein the application is the application in preparing feed for reducing the incidence of diseases, wherein: The diseases described are retained placenta and displaced abomasum.
5. The use according to claim 4, characterized in that: Each cow can freely eat the feed prepared by the functional package every day, and the feeding period is at least more than 1 month.
